Newman Mark
SEC CIK 1524597 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| CC | Chemours Co | Pres, CEO, Dir | 267.0K | $515.3K | $10.13M | 19 | 2021-07-01 | 2023-06-09 |
Most active insiders at CC, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Cowan Alister | Dir | $203.1K | — |
| 2 | CRANSTON MARY B | Dir | $95.0K | — |
| 3 | Dignam Denise | Chief Execitive Off | $50.5K | — |
| 4 | HOSTETTER SHANE | CFO | $50.0K | — |
| 5 | Familiar Calderon Gerardo | See Remarks | $30.1K | — |
| 6 | Martinko Joseph T. | See Remarks | $30.0K | — |
| 7 | Foley Michael Robert | See Remarks | $30.0K | — |
| 8 | Kava Joseph Daniel | Dir | — | — |
| 9 | Wellman Kristine M | SVP, GC, Corp. Sec | — | — |
| 10 | Will David | CAO | — | — |
Newman Mark made no open-market trades at CC in the last 12 months.
Transactions 19
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-06-12 | 2023-06-09 | CC | Chemours Co | Newman Mark | Pres, CEO, Dir | P - Purchase | $34.63 | +7,661 | 267.0K | +3% | +$265.3K | |
| A | 2023-06-12 | 2023-06-09 | CC | Chemours Co | Newman Mark | Pres, CEO, Dir | P - Purchase | $32.63 | +7,661 | 267.0K | +3% | +$250.0K |
| D | 2023-03-03 | 2023-03-01 | CC | Chemours Co | Newman Mark | Pres, CEO, Dir | F - Tax | $34.84 | -5,248 | 216.1K | -2% | -$182.8K |
| D | 2023-03-03 | 2023-03-01 | CC | Chemours Co | Newman Mark | Pres, CEO, Dir | A - Grant | $0.00 | +43.1K | 259.2K | +20% | $0 |
| 2023-02-14 | 2023-02-10 | CC | Chemours Co | Newman Mark | Pres, CEO, Dir | F - Tax | $34.35 | -71.0K | 221.3K | -24% | -$2.44M | |
| 2023-02-14 | 2023-02-10 | CC | Chemours Co | Newman Mark | Pres, CEO, Dir | A - Grant | $0.00 | +147.5K | 292.2K | +102% | $0 | |
| D | 2022-05-06 | 2022-05-05 | CC | Chemours Co | Newman Mark | Pres, CEO, Dir | S - Sale+OE | $40.22 | -197.2K | 176.3K | -53% | -$7.93M |
| D | 2022-05-06 | 2022-05-05 | CC | Chemours Co | Newman Mark | Pres, CEO, Dir | M - OptEx | $16.04 | +197.2K | 373.5K | +112% | +$3.16M |
| D | 2022-03-03 | 2022-03-01 | CC | Chemours Co | Newman Mark | Pres, CEO, Dir | F - Tax | $25.98 | -1,253 | 156.6K | -0.8% | -$32.6K |
| D | 2022-03-03 | 2022-03-01 | CC | Chemours Co | Newman Mark | Pres, CEO, Dir | A - Grant | $0.00 | +19.6K | 176.3K | +13% | $0 |
| 2022-02-15 | 2022-02-11 | CC | Chemours Co | Newman Mark | Pres, CEO, Dir | F - Tax | $30.00 | -7,133 | 157.9K | -4% | -$214.0K | |
| 2022-02-15 | 2022-02-11 | CC | Chemours Co | Newman Mark | Pres, CEO, Dir | A - Grant | $0.00 | +19.5K | 165.0K | +13% | $0 | |
| D | 2021-12-03 | 2021-12-02 | CC | Chemours Co | Newman Mark | Pres, CEO, Dir | S - Sale+OE | $29.94 | -34.3K | 145.5K | -19% | -$1.03M |
| D | 2021-12-03 | 2021-12-02 | CC | Chemours Co | Newman Mark | Pres, CEO, Dir | M - OptEx | $18.45 | +34.3K | 179.7K | +24% | +$631.9K |
| D | 2021-08-30 | 2021-08-27 | CC | Chemours Co | Newman Mark | Pres, CEO, Dir | M - OptEx | $18.45 | +29.7K | 175.1K | +20% | +$548.6K |
| D | 2021-08-30 | 2021-08-27 | CC | Chemours Co | Newman Mark | Pres, CEO, Dir | S - Sale+OE | $35.00 | -29.7K | 145.4K | -17% | -$1.04M |
| D | 2021-08-30 | 2021-08-30 | CC | Chemours Co | Newman Mark | Pres, CEO, Dir | M - OptEx | $18.45 | +3,691 | 149.1K | +3% | +$68.1K |
| D | 2021-08-30 | 2021-08-30 | CC | Chemours Co | Newman Mark | Pres, CEO, Dir | S - Sale+OE | $35.00 | -3,691 | 145.4K | -2% | -$129.2K |
| D | 2021-07-02 | 2021-07-01 | CC | Chemours Co | Newman Mark | Pres, CEO, Dir | A - Grant | $0.00 | +3,948 | 145.4K | +3% | $0 |
Purchase Sale Sale after option exercise All abbreviations